Fortis says it was ‘complete stranger’ to Daiichi-Singh Brothers arbitration dispute
Govt, private hospitals likely to be graded on quality & safety- CDSCO steps up scrutiny of pharma drugs containing narcotic substances
- Fortis Healthcare confident forensic audit will clear company in share transfer dispute
- -0.2613.345.8217.39
- -0.2213.365.7717.36
- -0.2813.345.8617.34
- Fortis defends itself after Supreme Court allows forensic audit, says it was "complete stranger" to Daiichi-Singh Brothers dispute
- Ayush services sector growing fast; projected to hit up to USD 318 billion by 2047: Study
- India needs five-year policy to make precision cancer care afforable, says expert
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in India
- SC clears forensic audit of Fortis-IHH deal involving erstwhile Religare promoters Singh brothers
- Before Ayushman Bharat, families sold their homes to afford treatment: J P Nadda
- Lord’s Mark advances AI breast cancer screening towards clinical trials
- Max Healthcare expands Africa footprint with new centre in Tanzania
- Supreme Court backs Delhi HC orders in Daiichi-Fortis dispute, clears way for forensic audit
- Alkem Laboratories CFO Nitin Agrawal resigns
- Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore
Top Mutual Funds
3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)
MORE NEWS
Biotech
NDude Labs invests in nutraceutical ingredients firm Nutriventia- MSD inaugurates 2.5 lakh sq ft tech centre in Hyderabad
- Govt eases loan licence requirement for 'outsourced' sterilisation of medical gear
- Danish firm Novonesis to roll out ₹3,000 crore Maharashtra investment over 2-3 years
- Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical
Healthcare
- Fortis says it was ‘complete stranger’ to Daiichi-Singh Brothers arbitration dispute
- Govt, private hospitals likely to be graded on quality & safety
- Fortis Healthcare confident forensic audit will clear company in share transfer dispute
- Fortis defends itself after Supreme Court allows forensic audit, says it was "complete stranger" to Daiichi-Singh Brothers dispute
- Ayush services sector growing fast; projected to hit up to USD 318 billion by 2047: Study
Pharmaceuticals
CDSCO steps up scrutiny of pharma drugs containing narcotic substances- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in India
- Max Healthcare expands Africa footprint with new centre in Tanzania
- Alkem Laboratories CFO Nitin Agrawal resigns
- The 30-Minute Medicine Problem